Thorax 2000;55:210-218 ( March )

Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999

Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society^*

Correspondence to: Dr I A Campbell

Received 10 May 1999; Returned to author 23 July 1999; Revised version received 14 October 1999; Accepted for publication 22 November 1999

The first 150 words of the full text of this article appear below.

	Introduction

Guidelines have been produced for tuberculosis by the British Thoracic Society (BTS),^1 2 the American Thoracic Society (ATS),³ the International Union Against Tuberculosis and Lung Disease,⁴ and the World Health Organisation.⁵ These, however, deal mainly with Mycobacterium tuberculosis complex infections (M tuberculosis, M africanum, and M bovis). With the exception of the ATS guidelines on non-tuberculous mycobacteria,³ these do not address the opportunist mycobacteria (also called atypical mycobacteria, mycobacteria other than tuberculosis (MOTT), non-tuberculous mycobacteria (NTM), or environmental mycobacteria).

The number of isolates of such opportunist mycobacteria has been increasing,⁶ both in HIV negative and HIV positive individuals. Because of the growing numbers of patients with disease due to infection by these mycobacteria, the wide range of species, the difficulties in both diagnosis and management, and in response to increasing requests for advice on management, the BTS Joint Tuberculosis Committee has reviewed the evidence on management of . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hoefsloot, W., van Ingen, J., de Lange, W. C. M., Dekhuijzen, P. N. R., Boeree, M. J., van Soolingen, D. (2009). Clinical relevance of Mycobacterium malmoense isolation in the Netherlands. Eur Respir J 34: 926-931 [Abstract] [Full Text]  
• Endean, A. L., Barry, S. M., Young-Min, S. A. (2009). Comment on: Possible miliary tuberculosis during adalimumab therapy with negative {gamma}-IFN release assays: reply. Rheumatology (Oxford) 48: 1178-1178 [Full Text]  
• van Ingen, J, Bendien, S A, de Lange, W C M, Hoefsloot, W, Dekhuijzen, P N R, Boeree, M J, van Soolingen, D (2009). Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 64: 502-506 [Abstract] [Full Text]  
• Andrejak, C, Lescure, F-X, Pukenyte, E, Douadi, Y, Yazdanpanah, Y, Laurans, G, Schmit, J-L, Jounieaux, V, and the Xenopi Group, (2009). Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax 64: 291-296 [Abstract] [Full Text]  
• Malkin, J., Shrimpton, A., Wiselka, M., Barer, M. R., Duddridge, M., Perera, N. (2009). Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease. J Med Microbiol 58: 371-373 [Abstract] [Full Text]  
• Santin, M., Dorca, J., Alcaide, F., Gonzalez, L., Casas, S., Lopez, M., Guerra, M. R. (2009). Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Eur Respir J 33: 148-152 [Abstract] [Full Text]  
• Jenkins, P A, Campbell, I A, Banks, J, Gelder, C M, Prescott, R J, Smith, A P (2008). Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 63: 627-634 [Abstract] [Full Text]  
• Kitada, S., Kobayashi, K., Ichiyama, S., Takakura, S., Sakatani, M., Suzuki, K., Takashima, T., Nagai, T., Sakurabayashi, I., Ito, M., Maekura, R., for the MAC Serodiagnosis Study Group, (2008). Serodiagnosis of Mycobacterium avium-Complex Pulmonary Disease Using an Enzyme Immunoassay Kit. Am. J. Respir. Crit. Care Med. 177: 793-797 [Abstract] [Full Text]  
• McGrath, E. E., Qureshi, N. (2007). Mycobacterium chelonei: friend or foe?. Eur Respir J 30: 397-397 [Full Text]  
• Marras, T. K, Chedore, P., Ying, A. M, Jamieson, F. (2007). Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax 62: 661-666 [Abstract] [Full Text]  
• Williams, K. J., Ling, C. L., Jenkins, C., Gillespie, S. H., McHugh, T. D. (2007). A paradigm for the molecular identification of Mycobacterium species in a routine diagnostic laboratory. J Med Microbiol 56: 598-602 [Abstract] [Full Text]  
• Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., Iseman, M., Olivier, K., Ruoss, S., von Reyn, C. F., Wallace, R. J. Jr., Winthrop, K., on behalf of the ATS Mycobacterial Diseases Subcom, (2007). An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am. J. Respir. Crit. Care Med. 175: 367-416 [Full Text]  
• Schonfeld, N. (2006). The mycobacterial mystery. Eur Respir J 28: 1076-1078 [Full Text]  
• Dailloux, M., Abalain, M. L., Laurain, C., Lebrun, L., Loos-Ayav, C., Lozniewski, A., Maugein, J., the French Mycobacteria Study Group, (2006). Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 28: 1211-1215 [Abstract] [Full Text]  
• Fowler, S. J., French, J., Screaton, N. J., Foweraker, J., Condliffe, A., Haworth, C. S., Exley, A. R., Bilton, D. (2006). Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J 28: 1204-1210 [Abstract] [Full Text]  
• Kunst, H., Wickremasinghe, M., Wells, A., Wilson, R. (2006). Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J 28: 352-357 [Abstract] [Full Text]  
• Field, S. K., Cowie, R. L. (2006). Lung Disease Due to the More Common Nontuberculous Mycobacteria. Chest 129: 1653-1672 [Abstract] [Full Text]  
• Koh, W.-J., Kwon, O. J., Jeon, K., Kim, T. S., Lee, K. S., Park, Y. K., Bai, G. H. (2006). Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea.. Chest 129: 341-348 [Abstract] [Full Text]  
• Wickremasinghe, M, Ozerovitch, L J, Davies, G, Wodehouse, T, Chadwick, M V, Abdallah, S, Shah, P, Wilson, R (2005). Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 60: 1045-1051 [Abstract] [Full Text]  
• Gillespie, S. H., Basu, S., Dickens, A. L., O'Sullivan, D. M., McHugh, T. D. (2005). Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J Antimicrob Chemother 56: 344-348 [Abstract] [Full Text]  
• Maliwan, N, Zvetina, J R (2005). Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience. Postgrad. Med. J. 81: 530-533 [Abstract] [Full Text]  
• Benton, N., Musaad, S., Vaughan, R., McLean, L. (2004). Recurrent multifocal Mycobacterium kansasii infection in an immunosuppressed patient with myelodysplasia and relapsing polychondritis. Rheumatology (Oxford) 43: 1453-1454 [Full Text]  
• Olafsson, E. J., Naum, C. C., Sarosi, G. A., Mastronarde, J. G. (2004). Bilateral Pleural Effusions and Right Pneumothorax in a 25-Year-Old Man. Chest 126: 986-992 [Full Text]  
• Henry, M.T., Inamdar, L., O'Riordain, D., Schweiger, M., Watson, J.P. (2004). Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 23: 741-746 [Abstract] [Full Text]  
• Primm, T. P., Lucero, C. A., Falkinham, J. O. III (2004). Health Impacts of Environmental Mycobacteria. Clin. Microbiol. Rev. 17: 98-106 [Abstract] [Full Text]  
• Miles, G, Walters, T K, Shee, C D (2003). Periprosthetic tuberculous breast infection. JRSM 96: 556-557 [Full Text]  
• Salazar-Schicchi, J, Nachman, S A, Bachmeyer, C, Stelianides, S, Blum, L (2002). Mycobacterium xenopi. Thorax 57: 658-658 [Full Text]  
• Gordon, M.-M., Wilson, H. E., Duthie, F. R., Jones, B., Field, M. (2002). When typical is atypical: mycobacterial infection mimicking cutaneous vasculitis. Rheumatology (Oxford) 41: 685-690 [Abstract] [Full Text]  
• ORMEROD, P (2001). A step forward in the evidence-based treatment of opportunist mycobacteria. Thorax 56: 163-163 [Full Text]  
• Research Committee of the British Thoracic Society, (2001). First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 56: 167-172 [Abstract] [Full Text]  
• PORTER-JONES, G. (2001). "Opportunist" mycobacterial infection. Thorax 56: 84a-84 [Full Text]  
• DAVIES, P D O, GRANGE;, J M, CAMPBELL, I A, ORMEROD, L P (2000). Antibiotic prescribing in the community.. Thorax 55: 722-722 [Full Text]